IRF9 and cancer: We compared the distribution of patient characteristics: cancer stage, histological grade, sex, and age, partitioned across four sub-groupings based on TGFB2 and IRF9 mRNA expression levels (Figure S1) and TGFB2 and IFI27 mRNA expression levels (Figure S2).